Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Micron Solutions, Inc. MICRD OTC

Other OTC • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
39/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Micron Solutions, Inc. (MICRD) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 37/100, indicating a weak investment profile with 1 out of 7 criteria passed.

Financials: revenue is $23M, +9.2%/yr average growth. Net income is $1M (loss), growing at +9.7%/yr. Net profit margin is -5.7% (negative). Gross margin is 12.6% (+2.5 pp trend).

Balance sheet: total debt is $5M against $5M equity (Debt-to-Equity (D/E) ratio 1.14, moderate). Current ratio is 1.69 (strong liquidity). Debt-to-assets is 45.5%. Total assets: $12M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 65/100 (Pass), Past 50/100 (Partial), Health 50/100 (Partial), Moat 22/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

MICRD SharesGrow Score Overview

39/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 65/100
Financials — average growth
PAST 50/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 22/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — MICRD

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✓
GROWTH Pass
65/100
MICRD: +9.2%/yr revenue is, +9.7%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
50/100
MICRD: 2 / 4 years profitable. weak. Score = 2 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
50/100
Balance sheet MICRD: Debt-to-Equity (D/E) ratio 1.14 (moderate), Current ratio is 1.69 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
22/100
MICRD: Gross margin is 12.6% (+2.5 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 22/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
MICRD: Net profit margin is -5.7%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.0001-1
Volume61
Avg Volume (30D)163
Market Cap$317.00
Beta (1Y)0.44
Share Statistics
EPS (TTM)-0.41
Shares Outstanding$3.15M
IPO Date2002-01-02
Employees82
CEOWilliam J. Laursen
Financial Highlights & Ratios
Revenue (TTM)$22.56M
Gross Profit$2.85M
EBITDA$-308.4K
Net Income$-1.29M
Operating Income$-1.18M
Total Cash$5.85K
Total Debt$5.44M
Net Debt$5.43M
Total Assets$11.95M
Price / Earnings (P/E)-0
Price / Sales (P/S)0
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS59511X2045

Price Chart

Track all markets on TradingView
MICRD
Micron Solutions, Inc. ↗  ·  Other OTC
Healthcare • Medical - Instruments & Supplies
0.00 52WK RANGE 1.00

People Also View

LLY
LLY
Eli Lilly and Company
$905.13
-1.88%
 JNJ
JNJ
Johnson & Johnson
$238.67
-0.60%
 ABBV
ABBV
AbbVie Inc.
$208.43
-0.87%
 RHHBF
RHHBF
Roche Holding AG
$415.00
-0.84%
 RHHBY
RHHBY
Roche Holding AG
$50.99
-0.08%
 AZN
AZN
AstraZeneca PLC
$201.21
-1.55%
 NVS
NVS
Novartis AG
$152.08
-0.85%
 MRK
MRK
Merck & Co., Inc.
$117.90
-1.72%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message